News

The Manila Times3d
BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 - an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
BioRestorative Therapies, Inc. ("BioRestorative,” "BRTX” or the "Company”) (NASDAQ: BRTX), a clinical-stage regenerative me ...
BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, announced ...